182 related articles for article (PubMed ID: 35570131)
1. Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research - 20 years of experience and future perspectives.
Mollnes TE; Storm BS; Brekke OL; Nilsson PH; Lambris JD
Semin Immunol; 2022 Jan; 59():101604. PubMed ID: 35570131
[TBL] [Abstract][Full Text] [Related]
2. Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole Blood.
Storm BS; Christiansen D; Fure H; Ludviksen JK; Lau C; Lambris JD; Woodruff TM; Brekke OL; Braaten T; Nielsen EW; Mollnes TE
J Immunol; 2021 Dec; 207(11):2828-2840. PubMed ID: 34732467
[TBL] [Abstract][Full Text] [Related]
3. A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity.
Nilsson PH; Johnson C; Quach QH; Macpherson A; Durrant O; Pischke SE; Fure H; Landsem A; Bergseth G; Schjalm C; Haugaard-Kedström LM; Huber-Lang M; van den Elsen J; Brekke OL; Mollnes TE
J Immunol; 2021 Sep; 207(6):1641-1651. PubMed ID: 34380648
[TBL] [Abstract][Full Text] [Related]
4. Venous Air Embolism Activates Complement C3 Without Corresponding C5 Activation and Trigger Thromboinflammation in Pigs.
Storm BS; Ludviksen JK; Christiansen D; Fure H; Pettersen K; Landsem A; Nilsen BA; Dybwik K; Braaten T; Nielsen EW; Mollnes TE
Front Immunol; 2022; 13():839632. PubMed ID: 35371063
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation.
Skjeflo EW; Christiansen D; Fure H; Ludviksen JK; Woodruff TM; Espevik T; Nielsen EW; Brekke OL; Mollnes TE
J Thromb Haemost; 2018 May; 16(5):905-918. PubMed ID: 29437288
[TBL] [Abstract][Full Text] [Related]
6. Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by Staphylococcus aureus in a human whole blood model.
Skjeflo EW; Christiansen D; Espevik T; Nielsen EW; Mollnes TE
J Immunol; 2014 Mar; 192(6):2857-64. PubMed ID: 24516199
[TBL] [Abstract][Full Text] [Related]
7. Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels.
Golomingi M; Kohler J; Lamers C; Pouw RB; Ricklin D; Dobó J; Gál P; Pál G; Kiss B; Dopler A; Schmidt CQ; Hardy ET; Lam W; Schroeder V
Front Immunol; 2023; 14():1226832. PubMed ID: 37771595
[TBL] [Abstract][Full Text] [Related]
8. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity.
Mannes M; Dopler A; Zolk O; Lang SJ; Halbgebauer R; Höchsmann B; Skerra A; Braun CK; Huber-Lang M; Schrezenmeier H; Schmidt CQ
Blood; 2021 Jan; 137(4):443-455. PubMed ID: 33507296
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue Factor.
Gravastrand CS; Steinkjer B; Halvorsen B; Landsem A; Skjelland M; Jacobsen EA; Woodruff TM; Lambris JD; Mollnes TE; Brekke OL; Espevik T; Rokstad AMA
J Immunol; 2019 Aug; 203(4):853-863. PubMed ID: 31270150
[TBL] [Abstract][Full Text] [Related]
10. C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocycles.
Furlong ST; Dutta AS; Coath MM; Gormley JJ; Hubbs SJ; Lloyd D; Mauger RC; Strimpler AM; Sylvester MA; Scott CW; Edwards PD
Immunopharmacology; 2000 Jul; 48(2):199-212. PubMed ID: 10936517
[TBL] [Abstract][Full Text] [Related]
11. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature.
Lappegård KT; Christiansen D; Pharo A; Thorgersen EB; Hellerud BC; Lindstad J; Nielsen EW; Bergseth G; Fadnes D; Abrahamsen TG; Høiby EA; Schejbel L; Garred P; Lambris JD; Harboe M; Mollnes TE
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15861-6. PubMed ID: 19717455
[TBL] [Abstract][Full Text] [Related]
12. Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models.
Zwarthoff SA; Berends ETM; Mol S; Ruyken M; Aerts PC; Józsi M; de Haas CJC; Rooijakkers SHM; Gorham RD
Front Immunol; 2018; 9():1691. PubMed ID: 30083158
[TBL] [Abstract][Full Text] [Related]
13. Artificial surface-induced inflammation relies on complement factor 5: proof from a deficient person.
Bergseth G; Lambris JD; Mollnes TE; Lappegård KT
Ann Thorac Surg; 2011 Feb; 91(2):527-33. PubMed ID: 21256307
[TBL] [Abstract][Full Text] [Related]
14. Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.
Müller-Calleja N; Ritter S; Hollerbach A; Falter T; Lackner KJ; Ruf W
Blood Adv; 2018 May; 2(9):979-986. PubMed ID: 29716893
[TBL] [Abstract][Full Text] [Related]
15. With complements: C3 inhibition in the clinic.
Kolev M; Barbour T; Baver S; Francois C; Deschatelets P
Immunol Rev; 2023 Jan; 313(1):358-375. PubMed ID: 36161656
[TBL] [Abstract][Full Text] [Related]
16. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.
Subramaniam S; Jurk K; Hobohm L; Jäckel S; Saffarzadeh M; Schwierczek K; Wenzel P; Langer F; Reinhardt C; Ruf W
Blood; 2017 Apr; 129(16):2291-2302. PubMed ID: 28223279
[TBL] [Abstract][Full Text] [Related]
17.
Gerogianni A; Bal M; Mohlin C; Woodruff TM; Lambris JD; Mollnes TE; Sjöström DJ; Nilsson PH
Front Immunol; 2023; 14():1101387. PubMed ID: 37081885
[TBL] [Abstract][Full Text] [Related]
18. A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention.
Zewde N; Morikis D
PLoS One; 2018; 13(6):e0198644. PubMed ID: 29874282
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway.
Krisinger MJ; Goebeler V; Lu Z; Meixner SC; Myles T; Pryzdial EL; Conway EM
Blood; 2012 Aug; 120(8):1717-25. PubMed ID: 22802338
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody-mediated arthritis in the absence of C3 and activating Fcγ receptors: C5 is activated by the coagulation cascade.
Auger JL; Haasken S; Binstadt BA
Arthritis Res Ther; 2012 Dec; 14(6):R269. PubMed ID: 23237573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
